Research Article
Elevated Circulating Levels of Inflammatory Markers in Patients with Acute Coronary Syndrome
Table 2
Clinical characteristics of patients.
| | Characteristics | CAD | ACS | | ( = 50) | ( = 20) |
| | Age (years) | 70 ± 7 | 65 ± 11 | | Sex (male/female) | 40/10 | 19/1 | | Risk factors | | | | Family history, (%) | 13 (26) | 6 (30) | | Hypertension, (%) | 38 (76) | 12 (60) | | Diabetes, (%) | 21 (42) | 5 (25) | | Smoking, (%) | 35 (70) | 13 (65) | | Body mass index | 24.5 ± 3.7 | 24.1 ± 2.5 | | Systolic BP (mm Hg) | 138 ± 19 | 139 ± 25 | | Diastolic BP (mm Hg) | 78 ± 12 | 81 ± 17 | | Laboratory measurements | | | | TC (mg/dL) | 165 ± 28 | 189 ± 44 | | TG (mg/dL) | 120 ± 48 | 155 ± 106 | | LDL cholesterol (mg/dL) | 96 ± 26 | 114 ± 34 | | HDL cholesterol (mg/dL) | 45 ± 13 | 48 ± 10 | | Creatinine (mg/dL) | 0.84 ± 0.22 | 0.77 ± 0.26 | | HbA1c (%) | 5.8 ± 0.7 | 5.7 ± 0.8 | | Hs-CRP (mg/dL) | 0.12 ± 0.16 | 0.13 ± 0.07 | | BNP (pg/mL) | 57 ± 72 | 89 ± 121 | | Medications, (%) | | | | Antiplatelet | 50 (100) | 20 (100) | | β-blocker | 24 (48) | 6 (30) | | ACEI/ARB | 27 (54) | 11 (55) | | CCB | 23 (46) | 6 (30) | | Statin | 32 (64) | 12 (60) | | Antianginal drug | 16 (32) | 2 (10) |
|
|
The data are presented as mean ± SD. CAD: coronary artery disease; ACS: acute coronary syndrome; BP: blood pressure; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; HDL: high-density lipoprotein; Hb: hemoglobin; Hs-CRP: high-sensitivity C-reactive protein; BNP: brain natriuretic peptide; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. .
|
